The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Marker Therapeutics, Inc(NASDAQ:MRKR) 
Marker Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Its MultiTAA-specific T cell technolog...
Website: http://www.markertherapeutics.com
Founded: 1992
Full Time Employees: 28
Sector: Healthcare
Industry: Biotechnology
Marker Therapeutics Number of Twitter Followers
Marker Therapeutics Days Payable Outstanding ttm (DPO)
Marker Therapeutics Days Receivable Outstanding ttm (DSO)
Marker Therapeutics Days Inventory Outstanding ttm (DIO)
Marker Therapeutics Op Cashflow Per Share ttm
Marker Therapeutics Free Cashflow Per Share ttm
Marker Therapeutics Cash Per Share ttm
Marker Therapeutics P/S ratio ttm
Marker Therapeutics (GAAP) P/E ratio ttm
Marker Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.